Jeroen Lammerts van Bueren

Direct in Vitro Comparison of Daratumumab with Surrogate Analogs of CD38 Antibodies MOR03087, SAR650984 and Ab79

Jeroen Lammerts van Bueren, Danielle Jakobs, Niels Kaldenhoven et al. · Blood · 2014 · 217 citations

The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia–Microenvironment Interactions in Chronic Lymphocytic Leukemia

Alba Matas‐Céspedes, Anna Vidal‐Crespo, Vanina Rodríguez et al. · Clinical Cancer Research · 2016 · 51 citations · Full text

Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens

Anna Vidal‐Crespo, Alba Matas‐Céspedes, Vanina Rodríguez et al. · Haematologica · 2019 · 42 citations · Full text

Phagocytosis Is A Mechanism of Action for Daratumumab

Marije B. Overdijk, Sandra Verploegen, Bögels Marijn et al. · Blood · 2012 · 18 citations

Daratumumab, a Novel Human Anti-CD38 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia and B-Cell Non–Hodgkin Lymphoma

Alba Matas‐Céspedes, Anna Vidal‐Crespo, Vanina Rodríguez et al. · Blood · 2012 · 13 citations